12:00 AM
 | 
Jul 02, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Emend aprepitant regulatory update

Japan's Ministry of Health, Labor and Welfare (MHLW) approved to expand the label of Emend aprepitant capsules to include chemotherapy-induced nausea and vomiting (CINV) in...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >